JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China

SCOPE: This study aimed to evaluate the effects of JK5G postbiotics to regulate imbalanced gut microbiota and its impacts on the efficacy and incidence rate of immune-related adverse events (irAEs) in non-small-cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs). METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Mengting, Ma, Liling, Yu, Huiqing, Huang, Shaoyi, Zhang, Junhui, Gong, Juan, Yang, Liejun, Chen, Lan, Luo, Haojun, Tian, Ling, Wang, Sixiong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436471/
https://www.ncbi.nlm.nih.gov/pubmed/37601658
http://dx.doi.org/10.3389/fonc.2023.1155592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436471/
https://www.ncbi.nlm.nih.gov/pubmed/37601658
http://dx.doi.org/10.3389/fonc.2023.1155592

Ejemplares similares